CS59492A3 - Canglemycin c, process of its preparation, its use, a pharmaceutical and astrain for said canglemycin c preparation - Google Patents
Canglemycin c, process of its preparation, its use, a pharmaceutical and astrain for said canglemycin c preparation Download PDFInfo
- Publication number
- CS59492A3 CS59492A3 CS92594A CS59492A CS59492A3 CS 59492 A3 CS59492 A3 CS 59492A3 CS 92594 A CS92594 A CS 92594A CS 59492 A CS59492 A CS 59492A CS 59492 A3 CS59492 A3 CS 59492A3
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- kanglemycin
- physiologically active
- active substance
- pharmaceutically acceptable
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
- C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/365—Nocardia
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Transplantation (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compounds Of Unknown Constitution (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN91101127A CN1037526C (zh) | 1991-03-01 | 1991-03-01 | 康乐霉素c的生产方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CS59492A3 true CS59492A3 (en) | 1992-09-16 |
Family
ID=4904964
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CS92594A CS59492A3 (en) | 1991-03-01 | 1992-02-28 | Canglemycin c, process of its preparation, its use, a pharmaceutical and astrain for said canglemycin c preparation |
Country Status (10)
Country | Link |
---|---|
US (1) | US5275817A (zh) |
EP (1) | EP0501399A1 (zh) |
JP (1) | JPH0570470A (zh) |
KR (1) | KR920018226A (zh) |
CN (1) | CN1037526C (zh) |
AU (1) | AU1119892A (zh) |
CA (1) | CA2061642A1 (zh) |
CS (1) | CS59492A3 (zh) |
HU (1) | HUT63883A (zh) |
IL (1) | IL101103A0 (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004002367A1 (fr) * | 2002-06-27 | 2004-01-08 | Microport Medical (Shanghai) Co., Ltd. | Stent eluant des medicaments |
US6908484B2 (en) | 2003-03-06 | 2005-06-21 | Spinecore, Inc. | Cervical disc replacement |
-
1991
- 1991-03-01 CN CN91101127A patent/CN1037526C/zh not_active Expired - Fee Related
-
1992
- 1992-02-21 CA CA002061642A patent/CA2061642A1/en not_active Abandoned
- 1992-02-21 US US07/839,614 patent/US5275817A/en not_active Expired - Fee Related
- 1992-02-24 AU AU11198/92A patent/AU1119892A/en not_active Abandoned
- 1992-02-25 KR KR1019920002846A patent/KR920018226A/ko not_active Application Discontinuation
- 1992-02-25 EP EP92103139A patent/EP0501399A1/en not_active Withdrawn
- 1992-02-25 JP JP4037966A patent/JPH0570470A/ja active Pending
- 1992-02-28 HU HU9200677A patent/HUT63883A/hu unknown
- 1992-02-28 IL IL101103A patent/IL101103A0/xx unknown
- 1992-02-28 CS CS92594A patent/CS59492A3/cs unknown
Also Published As
Publication number | Publication date |
---|---|
CN1064504A (zh) | 1992-09-16 |
HUT63883A (en) | 1993-10-28 |
CN1037526C (zh) | 1998-02-25 |
IL101103A0 (en) | 1992-11-15 |
EP0501399A1 (en) | 1992-09-02 |
HU9200677D0 (en) | 1992-05-28 |
AU1119892A (en) | 1992-09-03 |
KR920018226A (ko) | 1992-10-21 |
US5275817A (en) | 1994-01-04 |
JPH0570470A (ja) | 1993-03-23 |
CA2061642A1 (en) | 1992-09-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3140228B2 (ja) | 新規な大環状ラクトンおよびその生産菌 | |
EP1751272B1 (en) | Production of tacrolimus (fk-506) using new streptomyces species | |
MXPA97003484A (en) | Macrocyclic lactone compounds and their product procedure | |
EP1211259B1 (en) | Antibiotic caprazamycins and process for producing the same | |
FR2568892A1 (fr) | Nouvel antibiotique sandramycine, procede de preparation de celui-ci, culture biologiquement pure du micro-organisme nocardioides sp, atcc no 39419, et composition pharmaceutique contenant la sandramycine | |
KR840001258B1 (ko) | 신항생물질 mf 266 물질의 제조방법 | |
CS59492A3 (en) | Canglemycin c, process of its preparation, its use, a pharmaceutical and astrain for said canglemycin c preparation | |
US6852715B1 (en) | Indolocarbazole alkaloids from a marine actinomycete | |
US5002959A (en) | BU-4146T antibiotic | |
CA1263621A (en) | Fr-900848 substance and preparation thereof | |
EP0818464A1 (en) | Methylsulfomycin l, a process for its production and its use | |
US20130130992A1 (en) | Dipeptide derivative for the treatment of cancer | |
EP1324980B1 (en) | Citrullimycines, a process for their production and their use as pharmaceuticals | |
CA2020878C (en) | Antitumor antibiotic bu-3285t | |
JP2989674B2 (ja) | 制癌性物質サイトブラスチンおよびその製造法 | |
EP0205308B1 (en) | Scytophycins | |
ITMI950865A1 (it) | Derivati della purporogallina | |
JPS6332437B2 (zh) | ||
KR860001215B1 (ko) | 안지오텐신-전환 효소 억제제의 제조방법 | |
JPH03255082A (ja) | 新規抗生物質rk―441s、その製造法、抗腫瘍剤並びに免疫抑制剤 | |
JP2000178244A (ja) | 免疫抑制物質ic202a,bおよびc物質とその製造法 | |
FR2550536A1 (fr) | Desacetyl-ravidomycine, son procede de production et son application en therapeutique | |
JPH06228185A (ja) | D329物質とその誘導体,その製造法及び用途 | |
JPH05155885A (ja) | 新規hp530c2 物質及びその製造法 | |
WO2004046368A1 (ja) | 新規抗生物質ムラミノミシン(Muraminomicin) |